EC expands use to protect youngest children

New therapy aims to tackle antibiotic resistance

Regulators assess PB016 vedolizumab biosimilar applications

Researchers highlight minimally invasive monitoring potential

First-in-human evaluation of infinitopes’ therapeutic platform